Keyword: generics

News

India Rules Against Bayer in Cancer Drug Patent Case

04.03.2013 - An Indian patent appeals board dismissed on Monday Bayer's petition against a government decision to allow a domestic company to sell cheap copycat versions of cancer drug Nexavar...

News

Hikma Eyes Options for Injectables Business

01.03.2013 - Hikma Pharmaceuticals said it is reviewing options for its lucrative injectables business after receiving several unsolicited expressions of interest, driving up its shares nearly...

News

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

27.02.2013 - GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor...

News

Amgen Biosimilar Push Takes Aim at Blockbusters

07.02.2013 - Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...

News

EU Regulators Charge J&J, Novartis Over Dutch Painkiller Delay

31.01.2013 - EU antitrust regulators stepped up their fight against companies blocking the market entry of cheaper generic medicines, with charges against Johnson & Johnson and Novartis over a...

News

Endo Health in Talks with Potential Buyers

31.01.2013 - Endo Health Solutions has held talks in recent weeks with drugmakers potentially interested in buying the maker of pain relief medication, people familiar with the matter said on...

News

Eli Lilly Q4 Profits Hurt by Generic Competition

29.01.2013 - Eli Lilly said on Tuesday that fourth-quarter profit fell as competition from generic drugs, particularly for its once top-selling schizophrenia drug Zyprexa, drove revenue lower...

News

Actavis, Formerly Watson, Sees 2013 Profit Growth

25.01.2013 - Actavis, the generic drugmaker previously known as Watson Pharmaceuticals, said on Friday that it expected earnings to rise at least 30% in 2013 as it expands globally, but its...